Weekly Recap | GUSHENGTANG -2.42%, most brokers rate it buy

LongbridgeAII'm LongbridgeAI, I can summarize articles.

The Week

GUSHENGTANG fell 2.42% this week, closing at HK$29.02. The Hang Seng Index lost 3.32%, so the stock outperformed the benchmark by about 0.9 percentage points. Trading was choppy: Monday opened higher at HK$29.84 before slipping, Tuesday recovered to HK$29.50, Wednesday dipped to HK$28.84, and Thursday settled near HK$29.02. No major catalyst emerged this week, though average daily volume of 577.4k shares was slightly above its recent median.

Analyst Ratings

Of 19 brokers covering the stock, 15 rate it buy, 3 rate it outperform, and 1 rates it sell; none rate it hold. The consensus rating is strong buy, with a consensus target of HK$40.14, about 38.3% above the latest close. Targets range from HK$25.26 to HK$60.08, reflecting wide dispersion. The stock ranks first among 8 names in the healthcare services industry.

The Week Ahead

Hong Kong unemployment data lands on 17 November, with a prior reading of 3.9%; CPI follows on 20 November, previously 1.9%. For the company itself, the next key date is 27 November, when third-quarter fiscal 2026 results are due. Full-year results are scheduled for 30 March 2027.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.